Esperion Therapeutics Shares Are Trading Higher. The Stock May Be Moving on Continued Strength After Reporting Better-than-expected Q3 Financing Results Yesterday. Also, HC Wainwright & Co. Reiterated a Buy Rating on the Stock.
Esperion Therapeutics Shares Are Trading Higher. The Stock May Be Moving on Continued Strength After Reporting Better-than-expected Q3 Financing Results Yesterday. Also, HC Wainwright & Co. Reiterated a Buy Rating on the Stock.
esperion therapeutics股份正在交易上漲。該股可能是基於昨天發佈的超出預期的第三季度融資業績繼續走強。此外，HC Wainwright & Co.重申了對該股票的買入評級。
Esperion Therapeutics Shares Are Trading Higher. The Stock May Be Moving on Continued Strength After Reporting Better-than-expected Q3 Financing Results Yesterday. Also, HC Wainwright & Co. Reiterated a Buy Rating on the Stock.
esperion therapeutics股份正在交易上漲。該股可能是基於昨天發佈的超出預期的第三季度融資業績繼續走強。此外，HC Wainwright & Co.重申了對該股票的買入評級。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。